Mondrian Investment Partners LTD trimmed its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 1.7% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 305,912 shares of the healthcare conglomerate’s stock after selling 5,239 shares during the quarter. UnitedHealth Group accounts for 1.5% of Mondrian Investment Partners LTD’s investment portfolio, making the stock its 20th largest holding. Mondrian Investment Partners LTD’s holdings in UnitedHealth Group were worth $59,913,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Harbour Capital Advisors LLC grew its stake in shares of UnitedHealth Group by 18,383.4% during the 2nd quarter. Harbour Capital Advisors LLC now owns 2,516,706 shares of the healthcare conglomerate’s stock worth $13,573,000 after acquiring an additional 2,503,090 shares during the period. Janus Henderson Group PLC grew its stake in shares of UnitedHealth Group by 1,820.1% during the 2nd quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock worth $442,896,000 after acquiring an additional 2,264,242 shares during the period. Vanguard Group Inc. grew its stake in shares of UnitedHealth Group by 2.5% during the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after acquiring an additional 1,588,516 shares during the period. Parametric Portfolio Associates LLC boosted its stake in UnitedHealth Group by 77.3% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock worth $664,570,000 after purchasing an additional 1,562,661 shares during the period. Finally, Jennison Associates LLC boosted its stake in UnitedHealth Group by 180.4% in the 2nd quarter. Jennison Associates LLC now owns 2,252,507 shares of the healthcare conglomerate’s stock worth $417,660,000 after purchasing an additional 1,449,130 shares during the period. 86.01% of the stock is owned by institutional investors and hedge funds.
Several research analysts have commented on UNH shares. Goldman Sachs Group started coverage on UnitedHealth Group in a research note on Wednesday, January 3rd. They issued a “buy” rating and a $269.00 target price for the company. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. Morgan Stanley raised their target price on UnitedHealth Group from $215.00 to $235.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 18th. ValuEngine cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Finally, Leerink Swann reaffirmed a “buy” rating and issued a $240.00 price target (up from $225.00) on shares of UnitedHealth Group in a research note on Wednesday, October 18th. Three investment analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $226.74.
UnitedHealth Group Inc (UNH) opened at $224.35 on Thursday. UnitedHealth Group Inc has a one year low of $156.09 and a one year high of $231.77. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70. The stock has a market capitalization of $216,770.00, a price-to-earnings ratio of 25.49, a price-to-earnings-growth ratio of 1.57 and a beta of 0.66.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The firm had revenue of $50.32 billion during the quarter, compared to analysts’ expectations of $50.38 billion. During the same quarter in the previous year, the business earned $2.17 earnings per share. The company’s revenue was up 8.7% on a year-over-year basis. equities research analysts forecast that UnitedHealth Group Inc will post 9.99 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st were paid a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.34%. The ex-dividend date of this dividend was Thursday, November 30th. UnitedHealth Group’s dividend payout ratio is currently 34.09%.
In related news, Director Kenneth Irwin Shine sold 457 shares of the company’s stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total transaction of $96,440.71. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Larry C. Renfro sold 22,598 shares of the company’s stock in a transaction on Friday, December 15th. The shares were sold at an average price of $221.75, for a total value of $5,011,106.50. Following the sale, the chief executive officer now owns 195,314 shares of the company’s stock, valued at approximately $43,310,879.50. The disclosure for this sale can be found here. Insiders sold 34,630 shares of company stock valued at $7,669,416 in the last 90 days. Company insiders own 0.89% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Mondrian Investment Partners LTD Reduces Position in UnitedHealth Group Inc (UNH)” was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another website, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The correct version of this piece can be accessed at https://www.dispatchtribunal.com/2018/01/11/unitedhealth-group-inc-unh-position-decreased-by-mondrian-investment-partners-ltd.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.